Venclexta is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Venetoclax.
| Product ID | 0074-0576_2284c7ad-cd64-4d4c-0355-1e21172bba43 |
| NDC | 0074-0576 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Venclexta |
| Generic Name | Venetoclax |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-04-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208573 |
| Labeler Name | AbbVie Inc. |
| Substance Name | VENETOCLAX |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | BCL-2 Inhibitor [EPC],Increased Cellular Death [PE],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-04-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208573 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-04-11 |
| Marketing Category | NDA |
| Application Number | NDA208573 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-04-11 |
| Marketing Category | NDA |
| Application Number | NDA208573 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-11-21 |
| Ingredient | Strength |
|---|---|
| VENETOCLAX | 100 mg/1 |
| SPL SET ID: | b118a40d-6b56-cee3-10f6-ded821a97018 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-0561 | Venclexta | Venetoclax |
| 0074-0566 | Venclexta | Venetoclax |
| 0074-0576 | Venclexta | Venetoclax |
| 0074-0579 | Venclexta | Venetoclax |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VENCLEXTA 86855625 5079634 Live/Registered |
AbbVie Inc. 2015-12-21 |
![]() VENCLEXTA 86560752 5078740 Live/Registered |
AbbVie Inc. 2015-03-11 |